Ascendis Pharma A/s
(NASDAQ) ASND
Ascendis Pharma A/s Financials at a Glance
Market Cap
$13.07B
Revenue (TTM)
€867.51M
Net Income (TTM)
€506.60M
EPS (TTM)
$8.87
P/E Ratio
22.39
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$210.66
Volume
592,713.807
Open
$220.51
Price
$210.66
Volume
592,713.807
Open
$220.51
Previous Close
$210.45
Daily Range
$209.56 - $222.55
52-Week Range
$160.86 - $250.74
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$210.66
Volume
592,713.807
Open
$220.51
Previous Close
$210.45
Daily Range
$209.56 - $222.55
52-Week Range
$160.86 - $250.74
Estimated Earnings Date
Aug 6, 2026
ASND News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ascendis Pharma A/s
Industry
Biotechnology
Sector
Health CareCEO
Jan Møller Mikkelsen
Website
www.ascendispharma.comHeadquarters
Hellerup, 2900, DK
ASND Financials
Key Financial Metrics (TTM)
Gross Margin
88%
Operating Margin
-1%
Net Income Margin
58%
Return on Equity
326%
Return on Capital
-1%
Return on Assets
25%
Earnings Yield
4.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.07B
Shares Outstanding
62.11M
Volume
592.71K
Avg. Volume
633.40K
Financials (TTM)
Gross Profit
€588.53M
Operating Income
-€130.89M
EBITDA
-€113.90M
Operating Cash Flow
€51.77M
Capital Expenditure
-€8.15M
Free Cash Flow
€43.62M
Cash & ST Invst.
€615.78M
Total Debt
€871.41M
Ascendis Pharma A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€250.66M
+148.3%
Gross Profit
€229.03M
+174.5%
Gross Margin
91.37%
N/A
Market Cap
$13.07B
N/A
Market Cap/Employee
$12.85M
N/A
Employees
1,017
N/A
Net Income
€639.69M
+776.0%
EBITDA
€29.51M
+166.7%
Quarterly Fundamentals
Net Cash
-€324.18M
+1.6%
Accounts Receivable
€196.81M
+195.1%
Inventory
€314.67M
+7.4%
Long Term Debt
€386.51M
+8.2%
Short Term Debt
€511.09M
+4.3%
Return on Assets
25.26%
N/A
Return on Invested Capital
-0.79%
N/A
Free Cash Flow
-€15.69M
-4.5%
Operating Cash Flow
-€7.85M
+45.2%